High Signal Intensity in the Dentate Nucleus and Globus Pallidus on Unenhanced T1-weighted MR Images: Relationship with Increasing Cumulative Dose of a Gadolinium-based Contrast Material, Radiology, vol.270, issue.3, pp.834-841, 2014. ,
Gadolinium Retention in the Dentate Nucleus and Globus Pallidus Is Dependent on the Class of Contrast Agent, Radiology, vol.275, issue.3, pp.783-791, 2015. ,
Safety of the Gadolinium-Based Contrast Agents for Magnetic Resonance Imaging, Focusing in Part on Their Accumulation in the Brain and Especially the Dentate Nucleus, Investigative Radiology, vol.51, issue.5, pp.273-279, 2016. ,
Gadolinium deposition in the brain, Magnetic Resonance Imaging, vol.34, issue.10, pp.1346-1350, 2016. ,
Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging, Radiology, vol.275, issue.3, pp.772-782, 2015. ,
T1-Weighted Hypersignal in the Deep Cerebellar Nuclei After Repeated Administrations of Gadolinium-Based Contrast Agents in Healthy Rats, Investigative Radiology, vol.50, issue.8, pp.473-480, 2015. ,
Toxicological and cytophysiological aspects of lanthanides action., Acta Biochimica Polonica, vol.47, issue.4, pp.1107-1114, 2000. ,
Gadolinium ? a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?, Nephrology Dialysis Transplantation, vol.21, issue.4, pp.1104-1108, 2006. ,
The role of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: A critical update, Critical Reviews in Toxicology, vol.44, issue.10, pp.895-913, 2014. ,
Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: a critical review, BioMetals, vol.21, issue.4, pp.469-490, 2008. ,
Stability of Gadolinium-Based Magnetic Resonance Imaging Contrast Agents in Human Serum at 37°C, Investigative Radiology, vol.43, issue.12, pp.817-828, 2008. ,
Comparative In Vivo Dissociation of Gadolinium Chelates in Renally Impaired Rats, Investigative Radiology, vol.46, issue.5, pp.292-300, 2011. ,
Quantification and Assessment of the Chemical Form of Residual Gadolinium in the Brain After Repeated Administration of Gadolinium-Based Contrast Agents, Investigative Radiology, vol.52, issue.7, pp.396-404, 2017. ,
One-year Retention of Gadolinium in the Brain: Comparison of Gadodiamide and Gadoterate Meglumine in a Rodent Model, Radiology, vol.288, issue.2, pp.424-433, 2018. ,
Gadolinium Retention in the Rat Brain: Assessment of the Amounts of Insoluble Gadolinium-containing Species and Intact Gadolinium Complexes after Repeated Administration of Gadolinium-based Contrast Agents, Radiology, vol.285, issue.3, pp.839-849, 2017. ,
Long-term Excretion of Gadolinium-based Contrast Agents: Linear versus Macrocyclic Agents in an Experimental Rat Model, Radiology, vol.290, issue.2, pp.340-348, 2019. ,
Preclinical investigation to compare different gadolinium-based contrast agents regarding their propensity to release gadolinium in vivo and to trigger nephrogenic systemic fibrosis-like lesions, European Radiology, vol.18, issue.10, pp.2164-2173, 2008. ,
Gadolinium Retention, Brain T1 Hyperintensity, and Endogenous Metals, Investigative Radiology, vol.53, issue.6, pp.328-337, 2018. ,
EMA issues final opinion on linear gadolinium agents, Reactions Weekly, vol.1663, issue.1, pp.2-2, 2017. ,
Food and Drug Administration (FDA) ,
Biodistribution of Radiolabeled, Formulated Gadopentetate, Gadoteridol, Gadoterate, and Gadodiamide in Mice and Rats, Investigative Radiology, vol.30, issue.6, pp.372-380, 1995. ,
The Issue of Gadolinium Retained in Tissues, Investigative Radiology, vol.53, issue.3, pp.167-172, 2018. ,
Gadolinium Deposition in the Brain in a Large Animal Model, Investigative Radiology, vol.54, issue.9, pp.531-536, 2019. ,
US FDA Guidances for Food Security, Handbook of Food Science, Technology, and Engineering - 4 Volume Set, 2005. ,
Methodological Aspects for Preclinical Evaluation of Gadolinium Presence in Brain Tissue, Investigative Radiology, vol.53, issue.9, pp.499-517, 2018. ,
, Appendix D: Guidance for Industry Bioanalytical Method Validation by the Food and Drug Administration, Tobacco Smoke Exposure Biomarkers, pp.247-264, 2015.
Tests for departure from normality. Empirical results for the distributions of b2 and ?b1, Biometrika, vol.60, issue.3, pp.613-622, 1973. ,
Detecting outliers when fitting data with nonlinear regression-a new method based on robust nonlinear regression and the false discovery rate, BMC Bioinformatics, vol.7, issue.1, p.123, 2006. ,
Identification and characterization of gadolinium(iii) complexes in biological tissue extracts, Metallomics, vol.2, issue.7, p.490, 2010. ,